
Computation-Driven Innovative Drug R&D Provider
!!! Major Good News !!!
Recently, XtalPi, in collaboration with IDEA Research Institute, developed an AI drug patent data extraction and analysis platform.PatSightAwardedSecond Prize in the Special Category of the Guangdong-Hong Kong-Macao Greater Bay Area Data Application Innovation Competition (Ranked First in the Biomedical Field)! This honor is not only an affirmation of the product's technical strength but also highlights its outstanding contributions to advancing drug research and development.
The road to research and development innovation has never been easy, especiallyPharmaceutical Research and Development Field: Searching for patents, drawing structures, analyzing data... Pharmaceutical chemistry experts often need to deal with hundreds of patents and tens of thousands of molecular data.Traditional patent analysis methods are not only time-consuming and labor-intensive but may also overlook critical information.
? And PatSight has brought change to all of this ——From precise extraction of patent data to data-driven scientific analysis, providing a "one-stop" efficient solution to help pharmaceutical chemistry experts focus on innovation itself. (Trial link attached at the end of the article)

Core Functionality for More Efficient R&D
Visual and interactive management interface makes data clear at a glance and avoids critical information.
Convenient (One-click)Advanced(AI-based) Complete ADMET Property Prediction
With just one click, molecular ADMET property predictions based on precise AI models can be completed, freeing medicinal chemistry experts from trial-and-error processes.
Convenient (One-click) Science (Based on data) Complete data analysis
Clear high-frequency fragment display and combination capabilities help efficient analysis and scientific decision-making.

Why Choose and Recommend?


